Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Rattus norvegicus | Voltage-gated potassium channel subunit Kv7.2 | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.002 | 0.0039 | 0.0039 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.2341 | 0.2341 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0737 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3716 | 0.3716 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.3716 | 0.3716 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0737 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.2341 | 0.2341 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3716 | 0.3716 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.2662 | 0.2662 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.3716 | 0.3716 |
Loa Loa (eye worm) | potassium voltage-gated channel subfamily Q member 5 | 0.0078 | 0.3821 | 0.3895 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.2662 | 0.2713 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.2341 | 0.2341 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.3716 | 0.3788 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.2341 | 0.2341 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0737 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3716 | 0.3716 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.2341 | 0.2341 |
Loa Loa (eye worm) | voltage-gated potassium channel | 0.0171 | 0.981 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.3821 | 0.3895 |
Schistosoma mansoni | voltage-gated potassium channel KCNQ | 0.0174 | 1 | 1 |
Echinococcus multilocularis | potassium voltage gated channel subfamily KQT | 0.0078 | 0.3821 | 0.3821 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2341 | 0.2341 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0737 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.3716 | 0.3788 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.3716 | 0.3788 |
Echinococcus granulosus | potassium voltage gated channel subfamily KQT | 0.0078 | 0.3821 | 0.3821 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3716 | 0.3716 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.143 | 0.1457 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.3716 | 0.3716 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.0737 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3716 | 0.3716 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.2662 | 0.2713 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0737 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.3821 | 0.3895 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0737 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.143 | 0.143 |
Brugia malayi | RNA binding protein | 0.0076 | 0.3716 | 0.3716 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.3716 | 0.3716 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.2341 | 0.2386 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0737 | 0.0751 |
Brugia malayi | hypothetical protein | 0.003 | 0.0737 | 0.0737 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2341 | 0.2341 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.2662 | 0.2662 |
Echinococcus multilocularis | potassium voltage gated channel subfamily KQT | 0.0174 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0737 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.143 | 0.143 |
Echinococcus granulosus | potassium channel KvQLT family member kqt 1 | 0.0174 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2341 | 0.2341 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AbsAC40 (functional) | > 15 uM | PubChem BioAssay. HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | 6.00957 uM | PUBCHEM_BIOASSAY: Dose response assay for compounds that inhibit KCNQ2 potassium channels on automated electrophysiological assay II. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.0282 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 3.9811 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.9811 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 8.9125 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | = 63.0957 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.